News
-
New US antibacterial
Friday | Sep 1 2017THE US FDA has approved Vabomere (meropenem/vaborbactam), a new antibacterial drug for the treatment of adults with complicated urinary tract infections (cUTIs).
-
ACCC rules on eRx
Friday | Sep 1 2017THE Australian Competition and Consumer Commission yesterday issued a draft determination, proposing to grant authorisation to eRx Script Exchange to give effect to its ongoing revenue sharing arrangement with IP MDS Pty Ltd (formerly MediSecure) through until 30 Jun 2020.
-
New surcharge rules
Friday | Sep 1 2017AUSTRALIAN businesses are now banned from charging more in credit card fees than they actually cost from the merchant service provider, under new rules which became effective nationally today.
-
CMA hails new draft legislation
Friday | Sep 1 2017COMPLEMENTARY Medicines Australia (CMA) has welcomed the release of the "exposure draft" of the Therapeutic Goods Amendment (2017 Measures No.
-
OTC snoring solution
Friday | Sep 1 2017PHARMACISTS are set to play a critical role in the introduction of a new over-the-counter snoring cessation therapy that offers relief to the thousands of Australians impacted by the condition.
-
Spring spotlight spots
Friday | Sep 1 2017THERE are just two spaces remaining for companies wanting to showcase their spring product specials for pharmacies in Pharmacy Daily's Spring Spotlight.
-
Victoria to scrutinise franchise applications
Friday | Sep 1 2017THE Victorian Pharmacy Authority has updated its approach to "complex licence applications" for pharmacy premises - designated as such if they involve third party commercial arrangements such as franchise agreements or arrangements with banner groups.
-
Reprimand removals policy
Friday | Sep 1 2017THE Pharmacy Board of Australia has advised of a new policy to ensure consistent removal of reprimands from the national register of practitioners.
-
TGA consults on advertising
Friday | Sep 1 2017THE Therapeutic Goods Administration has launched a consultation on proposed improvements to the Therapeutic Goods Advertising Code, including seeking comments on a possible framework for the advertising of Schedule 3 (pharmacist-only) medicines to the public.
-
South Australia’s PATY finalist
Friday | Sep 1 2017GAWLER Place Priceline Pharmacy pharmacy assistant Kimberley Hunt (pictured) has been chosen to represent South Australia at the National Finals of the 2017 Pharmacy Guild of Australia/ Maxigesic Pharmacy Assistant of the Year Award (PATY).
